ITeos Therapeutics Stock (NASDAQ: ITOS) stock price, news, charts, stock research, profile.
Open | $10.52 |
Close | - |
Volume / Avg. | 129.15K / 501.52K |
Day Range | $10.25 - $10.59 |
52 Wk Range | 8.20 - 18.75 |
Market Cap | $379.83M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 24 |
Short Interest | 13.39% |
Days to Cover | 9.38 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of ITeos Therapeutics (NASDAQ:ITOS) through any online brokerage.
Other companies in ITeos Therapeutics’s space includes: KalVista Pharma (NASDAQ:KALV), Voyager Therapeutics (NASDAQ:VYGR), Inozyme Pharma (NASDAQ:INZY), Korro Bio (NASDAQ:KRRO) and Larimar Therapeutics (NASDAQ:LRMR).
ITeos Therapeutics has a consensus price target of $37.00.
The stock price for ITeos Therapeutics (NASDAQ: ITOS) is $10.4 last updated September 24, 2024 at 10:52 AM EDT.
There are no upcoming dividends for ITeos Therapeutics.
ITeos Therapeutics’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
There is no upcoming split for ITeos Therapeutics.
ITeos Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.